Stay updated with breaking news from Statement Regarding. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
EQS-News: Defence Therapeutics Inc. / Key word(s): MiscellaneousDEFENCE’S ACCUM®-mRNA LIPID NANOPARTICLES ELICIT ANTIBODY RESPONSE 2X STRONGER THAN STANDARD mRNA VACCINES 25.09.2023 / 08:00 CET/CESTThe issuer is solely responsible for the content of this announcement. ___________________________________________...
TORONTO, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Latitude Uranium Inc. (“Latitude Uranium”, “LUR” or the “Company”) (CSE: LUR, OTCQB: LURAF, FRA: EI1) is...
Figure 1: Location of Phase 1 and Phase 2 drillholes, and potential new lens within the Lac 50 Trend. Figure 1: Location of Phase 1 and Phase 2 drillholes, and potential new lens within the Lac 50 Trend. TORONTO, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Latitude Uranium Inc. (“Latitude Uranium”, “LUR” or the “Company”) (CSE: LUR, OTCQB: LURAF, FRA: EI1) is pleased to announce the successful completion of its Phase 2 2023 drill program at the Angilak Project (“Angilak”) in Nunavut, Canada. The Phase 2
Hackett Also Launches Two New Solutions Offerings to Help Clients Understand the Impact of Artificial Intelligence ...
The US Commodity Futures Trading Commission (CFTC) recently settled enforcement actions against operators of three decentralized finance (DeFi) protocols (i.e., collections of smart...